Transchem Q1 FY27 Results (BSE: 500422)
Signal: Earnings grew
The read
The trajectory remains non-operating: revenue from operations was ₹0 lakh for both Q1FY27 and Q1FY26, while other income expanded 212.60% YoY to ₹511.36 lakh and drove PAT growth of 244.45% to ₹342.11 lakh; the key negative inflection is dilution, with diluted EPS down 29.63% YoY to ₹0.57 despite basic EPS rising 244.44%.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | 0 lakh | N/A | N/A |
| Net profit | ₹3.42 Cr | +244.45% | |
| EPS | ₹2.79 | +244.44% | |
| EBIT margin | N/A |
P&L walk
Standalone-only results: operating revenue remained ₹0 lakh YoY and QoQ, while other income rose to ₹511.36 lakh from ₹163.58 lakh YoY and ₹370.10 lakh QoQ; PAT increased to ₹342.11 lakh, but diluted EPS declined to ₹0.57 because of the 6,15,00,000 warrants.
Key positives
- PAT increased to ₹342.11 lakh, +244.45% YoY and +63.45% QoQ, supported by other income of ₹511.36 lakh, +212.60% YoY.
- Basic EPS rose to ₹2.79 from ₹0.81 YoY, tracking the reported PAT increase.
Key concerns
- Operating revenue remained ₹0 lakh for the quarter, so the ₹342.11 lakh PAT is not supported by a disclosed operating business.
- Diluted EPS declined to ₹0.57 from ₹0.81 YoY and ₹1.71 QoQ because 6,15,00,000 warrants were considered for dilution.
- Other income of ₹511.36 lakh represented 100% of total income, making earnings highly dependent on non-operating income.
Research and educational content only. Not investment advice.